Avanti Polar Lipids, part of Croda Pharma, develops innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics. We develop and manufacture highly specialised lipids used in Lipid Nanoparticle (LNP) delivery technology to solve the stability and delivery issues associated with mRNA-based vaccines and therapeutics. We have a wide portfolio of phospholipids, cationic lipids, PEG lipids and sterols. Our formulations division develops custom lipid-based drug delivery systems for a range of pharmaceutical applications. Our expertise is also in development, scale-up and manufacturing of lipids under cGMP. We also provide contract manufacturing services for proprietary lipids.
